Erectile dysfunction (ED) is more common than most men realize—and far more treatable than many believe. According to the Massachusetts Male Aging Study, approximately 52% of men between ages 40 and 70 experience some degree of ED, ranging from minimal to complete. Globally, the number of men affected exceeds 150 million, with projections suggesting that number will double by 2030 as the population ages and metabolic disease becomes more prevalent.

Despite this prevalence, ED remains heavily stigmatized. Many men suffer in silence for years before seeking help, often because they're embarrassed, unsure where to turn, or mistakenly believe it's an inevitable part of aging. It is not inevitable—and 2026 offers more effective treatment options than any prior period in medical history.

What Is Erectile Dysfunction?

Erectile dysfunction is defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual activity. The key word is persistent—occasional difficulty achieving an erection due to stress, fatigue, or alcohol consumption is entirely normal and does not constitute ED. The clinical threshold is typically difficulties occurring more than 25% of the time, persisting for at least 3 months.

An erection is a complex vascular event that requires the coordinated interplay of psychological signals, neural conduction, hormonal regulation, and vascular health. When any of these systems are disrupted, ED can result. This complexity is why understanding the underlying cause is essential for selecting the most effective treatment.

Causes of Erectile Dysfunction

ED has both organic (physical) and psychogenic (psychological) causes—and in many men, both contribute simultaneously.

Vascular Causes (Most Common)

The vast majority of ED in men over 40 has a vascular basis. An erection depends on adequate blood flow into the corpus cavernosum (erectile tissue) and the ability of smooth muscle to relax, trapping blood in penile tissue. When penile arteries become atherosclerotic—narrowed or stiffened by the same process that causes coronary artery disease—adequate blood flow cannot be achieved.

ED is now recognized as an early warning sign of cardiovascular disease. Research published in the Journal of the American College of Cardiology found that men with ED had a significantly higher 10-year risk of cardiovascular events, including heart attack and stroke. In many cases, ED precedes a cardiac event by 3–5 years. A new ED diagnosis in a man over 40 warrants cardiovascular risk assessment.

Neurological Causes

Erections depend on nerve signals traveling from the brain and spinal cord to penile tissue. Conditions that damage these pathways include:

  • Diabetes mellitus (peripheral neuropathy affecting autonomic nerves)
  • Multiple sclerosis
  • Parkinson's disease
  • Spinal cord injuries or surgery
  • Radical prostatectomy (nerve-sparing vs. non-nerve-sparing techniques significantly affect ED outcomes)

Hormonal Causes

Low testosterone (hypogonadism) reduces libido and can impair erectile function, though its direct contribution to the erectile mechanism is complex. Hyperprolactinemia (elevated prolactin, often from a pituitary adenoma) and thyroid disorders can also contribute. A hormonal panel is a standard part of the ED workup for men who don't respond to first-line treatments.

Psychological Causes

Performance anxiety, depression, relationship conflict, and generalized stress can all contribute to or perpetuate ED. Psychogenic ED is more common in younger men and is often characterized by the preservation of morning erections—suggesting the vascular and neural mechanisms are intact but the psychological trigger is disrupting function during partner sexual activity.

Depression is particularly important to note: both the condition and many antidepressants (especially SSRIs) can cause ED. In men taking SSRIs, switching to a medication with a different mechanism (e.g., bupropion) or adding a PDE5 inhibitor may be appropriate.

Medication-Induced ED

Numerous commonly prescribed medications can impair erectile function:

  • Antihypertensives: beta-blockers, thiazide diuretics (though calcium channel blockers and ACE inhibitors are typically less problematic)
  • SSRIs and SNRIs
  • Antiandrogens (used for prostate cancer)
  • H2 blockers (cimetidine)
  • Opioids (suppress testosterone and have direct neural effects)
  • Recreational drugs: alcohol (acute and chronic), cocaine, opiates

If a medication change coincided with the onset of ED, discussing alternatives with your prescribing physician is warranted.

Key Risk Factors for ED

While anyone can develop ED, certain factors substantially elevate risk:

  • Age: ED becomes more prevalent with each decade, though it's not an inevitable consequence of aging.
  • Cardiovascular disease: Hypertension, hyperlipidemia, and atherosclerosis directly impair penile blood flow.
  • Diabetes: Both type 1 and type 2 diabetes cause vascular and neurological damage. Diabetic men are 3 times more likely to develop ED.
  • Obesity: Excess weight reduces testosterone, promotes inflammation, and impairs vascular health.
  • Smoking: Nicotine is a potent vasoconstrictor and accelerates atherosclerosis. Smoking doubles the risk of ED.
  • Physical inactivity: Sedentary men have significantly higher rates of ED. Even moderate exercise reduces ED risk substantially.
  • Sleep disorders: Obstructive sleep apnea reduces nocturnal testosterone production and oxygenation, both of which contribute to ED.

ED Treatment Options in 2026

Treatment for ED has expanded well beyond the "little blue pill" that most men think of. Here's a comprehensive overview of current options:

1. PDE5 Inhibitors: First-Line Treatment

Phosphodiesterase type 5 (PDE5) inhibitors remain the cornerstone of ED treatment. They work by increasing cyclic GMP levels in penile smooth muscle, enhancing the vasodilatory effects of nitric oxide and facilitating blood flow in response to sexual stimulation.

  • Sildenafil (Viagra, generic): Effective in 70–85% of men with organic ED. Works within 30–60 minutes, lasts 4–6 hours. Available as inexpensive generic.
  • Tadalafil (Cialis, generic): Unique 36-hour duration allows for greater sexual spontaneity. Daily low-dose tadalafil (2.5–5 mg) provides continuous coverage and may improve endothelial function over time.
  • Vardenafil (Levitra, Staxyn): Comparable to sildenafil in efficacy. May work slightly faster for some men.
  • Avanafil (Stendra): Fastest onset (~15 minutes), with a favorable side-effect profile. Fewer reported visual disturbances than sildenafil.

PDE5 inhibitors are contraindicated with nitrate medications (nitroglycerin, isosorbide) due to risk of severe hypotension. Men on nitrates require alternative treatment approaches.

2. Testosterone Replacement Therapy (TRT)

For men with ED and confirmed low testosterone, TRT can improve sexual desire and may improve erectile function, particularly when combined with a PDE5 inhibitor. TRT alone does not reliably restore erections in men whose ED is primarily vascular, but restoring hormonal balance is an important foundational step. Learn more at Truventa Medical's TRT program.

3. PT-141 (Bremelanotide): Centrally Acting

PT-141 is an FDA-approved melanocortin receptor agonist that acts centrally—at the brain and spinal cord level—rather than peripherally like PDE5 inhibitors. It enhances sexual desire and arousal independent of vascular mechanisms, making it particularly valuable for men who don't respond adequately to PDE5 inhibitors alone or who have a significant psychogenic component to their ED.

PT-141 is administered as a subcutaneous injection 45 minutes before sexual activity. It's available through Truventa Medical's sexual health program and represents a meaningful advance for men whose ED hasn't responded to oral treatments.

4. Trimix and Bimix Injections

Intracavernosal injections (ICIs) of vasoactive agents directly into the corpus cavernosum are highly effective—producing erections in over 80% of men regardless of underlying cause, including those who don't respond to PDE5 inhibitors. Trimix (a combination of alprostadil, phentolamine, and papaverine) is the most commonly compounded formulation. While the concept of self-injection sounds daunting, most men who learn the technique find it manageable and reliably effective.

5. Vacuum Erection Devices (VEDs)

Mechanical pumps that create negative pressure around the penis, drawing blood into erectile tissue. Used with a constriction ring to maintain the erection. Effective in up to 90% of men and appropriate across all ED types and causes. Best suited for men with contraindications to medications or who prefer a non-pharmacological approach.

6. Low-Intensity Shockwave Therapy (LiSWT / GAINSWave)

Low-intensity extracorporeal shockwave therapy delivers acoustic waves to penile tissue, stimulating angiogenesis (new blood vessel formation) and potentially restoring native erectile function over time. Multiple clinical trials show improvements in erectile function scores in men with vasculogenic ED, with some studies suggesting benefits that persist beyond the treatment period. Typically administered as 6–12 in-office sessions over several weeks.

7. Penile Implants (Prosthetics)

For men with severe ED who have failed all other treatments, surgical implantation of an inflatable or malleable penile prosthesis offers highly effective, permanent restoration of erectile function. Satisfaction rates in published series exceed 90% for both patients and partners. Reserved for appropriate surgical candidates who have exhausted non-surgical options.

Lifestyle Modifications That May Improve ED

For mild to moderate ED—particularly in younger men—lifestyle changes can produce meaningful improvement and should be initiated regardless of whether medication is also prescribed:

  • Exercise: A meta-analysis in the Journal of Sexual Medicine found aerobic exercise significantly improved erectile function scores, particularly in men with cardiovascular risk factors.
  • Weight loss: Losing 10% of body weight has been shown to improve ED symptoms in obese men.
  • Smoking cessation: Quitting smoking produces measurable improvements in endothelial function within months.
  • Alcohol reduction: Heavy alcohol consumption directly impairs erectile function acutely and chronically.
  • Sleep optimization: Treating sleep apnea with CPAP has been shown to improve ED in multiple studies.

Getting Started with ED Treatment

The first step is a consultation with a physician who can evaluate the likely cause, screen for underlying cardiovascular or hormonal contributors, and recommend the most appropriate treatment. Truventa Medical's sexual health program makes this process entirely online, discreet, and accessible in all 50 states. There's no need to have an awkward conversation in a waiting room—our board-certified providers handle these conversations daily with complete professionalism and without judgment.

Most men with ED who seek treatment find a solution that works. The biggest barrier is simply taking the first step.

Key Takeaways

  • ED affects more than half of men between 40–70 and is not an inevitable consequence of aging.
  • The most common cause is vascular disease; a new ED diagnosis in older men warrants cardiovascular risk assessment.
  • PDE5 inhibitors (sildenafil, tadalafil) are first-line and effective in 70–85% of men.
  • PT-141, Trimix injections, and shockwave therapy provide additional options for non-responders.
  • Lifestyle modifications—exercise, weight loss, smoking cessation—meaningfully improve ED outcomes.
  • Treatment is accessible, discreet, and highly effective. Seeking help is the hardest part.